>
Haematologic TechnologiesHaematologic Technologies
Haematologic Technologies制造高質(zhì)量,血漿來源的凝血蛋白,抗體,因子缺陷型血漿和血液收集管,用于體外研究使用。我們確保產(chǎn)品制造流程確保質(zhì)量控制嚴(yán)格,努力成為一流凝血產(chǎn)品制造商。
Haematologic Technologies, Inc. (HTI) is a primary manufacturer that specializes in the isolation and characterization of high quality, humanplasmaproteins which are intended for in vitro research use. HTI’s emphasis is focused on proteins involved in theregulationof blood coagulation and fibrinolysis, as well as the regulation ofbonemetabolism. The HTI product line consists of over 150 highly purified and well-characterized proteins including zymogens, enzymes, cofactors, and inhibitors as well as a complementary line of monoclonal and polyclonal antibodies. Additionally, HTI offers a broad line of services, which includes: custom protein purification, protein modification, assay development, contract manufacturing and contract research.
產(chǎn)品列表:
Factor VII | Angiostatin |
Factor IX | Alpha-2-Plasmin Inhibitor |
Factor X | Factor V |
Factor XI | Factor Va |
Factor XII | Fibronectin |
Factor XIII | Protein S |
Plasminogen | von Willebrand Factor |
Protein C | Protein Z |
Prothrombin | Fibrinogen |
Activated Protein C | Beta-2-Glycoprotein 1 |
Thrombin (alpha) | Platelet Factor 4 |
Thrombin (beta, gamma) | Beta-Thromboglobulin |
Factor VIIa | Thrombospondin |
Factor IXa | Vitronectin |
Factor Xa | Recombinant Tissue Factor |
Factor XIa | Antithrombin III |
Factor XIIIa | Heparin Cofactor II |
Plasmin | TAFI |